FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Raizman

Research Profile

Chemicals & Drugs

Procedures

Objects

Excimer Lasers

Concepts & Ideas

Disorders

Physiology

Visual Acuity

Phenomena

Safety

Co-author Network

Publications

TOP 3
Eric D Donnenfeld; Louis D Nichamin; David R Hardten; Michael B Raizman; William Trattler; Rajesh K Rajpal; Louis M Alpern; Carlos Felix; Ronald R Bradford; Linda Villanueva; David A Hollander; Rhett M Schiffman
Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery.
Penny A Asbell; Kathryn A Colby; Sophie Deng; Peter J McDonnell; David M Meisler; Michael B Raizman; John D Sheppard; Daniel F Sahm
Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
Jason Jun; Leonard Bielory; Michael B Raizman
Vernal conjunctivitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Raizman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Eric D Donnenfeld; Louis D Nichamin; David R Hardten; Michael B Raizman; William Trattler; Rajesh K Rajpal; Louis M Alpern; Carlos Felix; Ronald R Bradford; Linda Villanueva; David A Hollander; Rhett M Schiffman
Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery.
American journal of ophthalmology 2011;151(3):420-6.e1.
2008: Penny A Asbell; Kathryn A Colby; Sophie Deng; Peter J McDonnell; David M Meisler; Michael B Raizman; John D Sheppard; Daniel F Sahm
Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
American journal of ophthalmology 2008;145(6):951-958.
2008: Jason Jun; Leonard Bielory; Michael B Raizman
Vernal conjunctivitis.
Immunology and allergy clinics of North America 2008;28(1):59-82, vi.
2008: Muna Ahmed; John H Niffenegger; Frederick Albert Jakobiec; Yael Ben-Arie-Weintrob; Nicolette Gion; Sofia Androudi; Robert Folberg; Michael B Raizman; Curtis E Margo; Morton E Smith; Ian W McLean; James G Caya; C Stephen Foster
Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation.
International ophthalmology 2008;28(1):35-46.
2007: Michael B Raizman; Eric D Donnenfeld; Arthur J Weinstein
Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery.
Current medical research and opinion 2007;23(10):2325-31.
2007: Tom Walters; Michael B Raizman; Paul Ernest; Johnny Gayton; Robert Lehmann
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Journal of cataract and refractive surgery 2007;33(9):1539-45.
2007: Eric D Donnenfeld; Edward J Holland; Daniel S Durrie; Michael B Raizman
Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy.
Advances in therapy 2007;24(4):852-62.
2007: Bennie H Jeng; Gary N Holland; Careen Y Lowder; William F Deegan; Michael B Raizman; David M Meisler
Anterior segment and external ocular disorders associated with human immunodeficiency virus disease.
Survey of ophthalmology 2007;52(4):329-68.
2005: Dal W Chun; Jeffrey S Heier; Michael B Raizman
Visual prosthetic device for bilateral end-stage macular degeneration.
Expert review of medical devices 2005;2(6):657-65.
2004: Kerry D Solomon; Eric D Donnenfeld; Michael B Raizman; Helga P Sandoval; Katherine Stern; Amanda VanDenburgh; Janet K Cheetham; Rhett M Schiffman
Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
Journal of cataract and refractive surgery 2004;30(8):1653-60.
2003: Amin Ashrafzadeh; Michael B Raizman
New modalities in the treatment of ocular allergy.
International ophthalmology clinics 2003;43(1):105-10.
2002: Michael B Raizman; Jay M Rubin; Adrienne L Graves; Michael Rinehart
Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers.
Clinical therapeutics 2002;24(9):1439-50.
2000: David M Meisler; Michael B Raizman; Elias Traboulsi
Oral erythromycin treatment for childhood blepharokeratitis.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus 2000;4(6):379-80.
1997: J P Gallo; Michael B Raizman
Phototherapeutic keratectomy for superficial corneal disorders.
International ophthalmology clinics 1997;37(1):155-70.